Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oftamedica is an Italian pharmaceutical company specializing in the research, development, and commercialization of ophthalmic products. The company's portfolio includes a diverse range of medical devices, nutritional supplements, and topical treatments designed to address various ocular conditions such as dry eye syndrome, blepharitis, and retinal health. Oftamedica focuses on providing innovative solutions for eye care professionals and patients, leveraging advanced formulations to improve ocular health and vision quality. The company is a significant player in the Italian ophthalmic market, particularly in the segments of ocular hygiene and nutritional support for eye health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oftamedica.